Haemophilia

Gene therapy for haemophilia: how far have we come?
pp. 699-703(5)
Authors: Fields P.A.; Pasi K.J.

Clotting factor concentrates and immune function in haemophilic patients
pp. 704-713(10)
Authors: Hoots K.; Canty D.

Causes of death in Canadians with haemophilia 1980–1995
pp. 714-720(7)
Authors: Walker I.R.; Julian J.A.

Prednisone and low-dose activated prothrombin complex concentrates for FVIII inhibitor in nonhaemophilic patients
pp. 721-724(4)
Authors: JI L.; Yang R.; Yang D.; Chen Z.; Xing S.; Tian M.; Sun Y.

Increased CD4-positive monocytes in HIV-infected haemophilic patients
pp. 725-730(6)
Authors: Riera N.; Galassi N.; Felippo M.; Ruibal-Ares B.; Bianco R.P.; Bracco M.D.

Laboratory and clinical markers of HIV infection in a national haemophilia cohort treated with recombinant factor VIII concentrate
pp. 731-738(8)
Authors: Teitel J.M.; Card R.; Strawczynski H.

Laboratory performance of haemophilia centres in developing countries: 3 years’ experience of the World Federation of Hemophilia External Quality Assessment Scheme
pp. 739-746(8)
Authors: Jennings I.; Kitchen S.; Woods T.A.L.; Preston F.E.

Total knee and hip arthroplasty in haemophilic patients
pp. 747-751(5)
Authors: Heeg M.; Meyer K.; Smid W.M.; Horn J.R.V.; Meer J.V.D.

An unusual haemarthrosis in an HIV-seronegative haemophilia A patient
pp. 752-754(3)
Authors: MÉnart C.; Duhaut P.; Attali O.; Dechavanne M.; NÉgrier C.

Development of a factor VIII inhibitor in a newborn haemophiliac
pp. 755-756(2)
Authors: Haya S.; Lorenzo J.I.; DasÍ M.A.; Aznar J.A.

Development of a subdural vein thrombosis following aggressive factor VII replacement for postnatal intracranial haemorrhage in a homozygous factor VII-deficient infant
pp. 757-761(5)
Authors: Worth L.L.; Hoots W.K.

Recombinant factor VIIa in continuous infusion during central line insertion in a child with factor VIII high-titre inhibitor
pp. 762-765(4)
Authors: Montoro J.B.; Altisent C.; Pico M.; CabaÑas M.J.; Vila M.; Puig L.L.

Does protease inhibitor treatment induce increased bleeding tendency in haemophilia?
pp. 766-767(2)
Authors: Mandalaki T.; Katsarou O.; Panagiotopoulou C.; Karafoulidou A.

Recurrent haemoperitoneum in a female patient with type III von Willebrand’s disease responded to administration of oral contraceptive
pp. 767-768(2)
Authors: Ghosh K.; Mohanty D.; Pathare A.V.; Jijina F.

Witnessing medical history: an interview with Dr Rosemary Biggs
pp. 769-777(9)

5th Musculoskeletal Congress of World Federation of Haemophilia, Sydney, Australia, 14–16 April 1999
pp. 778-778(1)